The Panodyne COVID-19 Antigen Rapid Lateral Flow Test Kit (nasopharyngeal swab/oropharyngeal swab), which has gained CE certification, is intended for Health Professional Use to help identify whether, for example, patients and those in social care settings (at the time of testing) have COVID-19 (Coronavirus) – even if no obvious symptoms are present.
Panodyne have been approved by UKHSA Porton Down which assesses lateral flow device performance characteristics to include a very high specificity, and sensitivity against viral loads associated with infectiousness desirable for the mass population & community-based testing.
We recommend you read the Official Government Guidance regarding SARS-COV-2 Lateral Flow Tests here.
Panodyne COVID-19 tests will detect the new Omicron Variant. Panodyne will continue to keep an eye on the variation of international novel coronavirus strains and will carry out verifications ot ensure they continue to stay abreast of detecting this evolving virus. For more information see lower down the page.
It’s quick and accurate. The point of care test uses a nasopharyngeal swab/oropharyngeal swab sample to detect the presence of the antigen produced by the body’s immune system, and a positive or negative result is visible within 15-20 minutes of testing, with accuracy of up to 97.04%.
Most tests require both a nose and throat swab in order to work correctly, however this test has been specifically formulated to work with either allowing the user to decide which they find most comfortable
These tests can be administered to both Adults & Children
Each individual test kit includes 1x test cassette, 1x sterile swab, 1x sample extraction tube, 1x dropper tip, 1x package insert, plus full usage instructions, which are all located inside a sealed test kit wallet.
Whilst the test kit works very quickly, requires no specialist equipment, is easy to use, and test results are easy to read, the manufacturers recommend that the kit should be administered by medically trained personnel. Also please note that if you are experiencing any COVID-19 symptoms, you must follow Government guidelines in terms of isolating and testing.
The results will inform you of the following, although please be aware that if the C line does not appear, the test is invalid. There is 1 negative and 1 positive result:
Negative Result: If only the quality control line (C) appears and the detection line (T) is not visible, then no novel coronavirus antigen has been detected and the result is negative.
Positive Result: C and T - if the quality control line (C) and the detection line (T) appears, then the novel coronavirus antigen has been detected and the result is positive. You currently have COVID-19.
It is recommended that you watch the video prior to administering the first test.
Please note that this test is not intended for home use.
A recent article was published on the National Health Executive website about Panodyne tests which can be read here.
Panodyne have produced a very useful Declaration Form for each of their test kits as attached which can be used each time someone is tested and kept as an internal record. Unlike PCR test kits, Lateral flow test kits do not need to be sent off to a lab to be processed and will provide results within 10-15 minutes. If the individual tested is positive, it is recommended that they immediately self-isolate and arrange to take a PCR test.
Panodyne sets the industry standards for unrivalled customer care and excellent client services from order to delivery, providing prompt replies and swift resolution to any queries. All Panodyne products are fully accredited and CE certified and registered with the MHRA where applicable.
With over 20 years of expertise, Panodyne is a well-established and trusted UK manufacturer with full ISO 9001:2015 and ISO:13845 quality management system accreditations. Its production facilities are regulated and audited under the strictest standards to guarantee high quality consistency and product availability, while products are also independently tested by global testing agencies such as SGS and Intertek. All products and medical devices are researched, designed and formulated in the UK and tested to the highest European standards to meet all legal requirements.
The requirements for free government tests that are being offered to companies with 50+ employees are important to take into account:
Once the tests have been delivered, a barcode for each test then has to be printed out, then the results have to be uploaded, including all the personal details of the person that has had the test.
If any companies don’t follow the process they won't get any more tests.
As an example, if a company has 100 employees and wants to test all 100 in one day, each test would take 10 minutes, each update of personaldata around 4 minutes, and barcode printing about 1 minute - so a totalof 16 minutes per test. So, 1600 minutes equals 26.6 hours for oneperson to test all 100 employees.
These tests are just as sensitive and save on all the paperwork. However, we do recommend that, if they test positive, the company sends the staff member for a government test and they follow guidelines regarding self-isolating.
On 26th of November, The Omicron variant was included as a fifth VOC (Variants of concern) by the World Health Organisation. Before this, the four known variants were Alpha, Beta, Gamma, Delta. SARS-CoV-2 Coronavirus Variant OMICRON Variants of Concern (VOC) Working definition: A SARS-CoV-2 variant that meets the definition of a VOI (see below) and, through a comparative assessment, has been demonstrated to be associated with one or more of the following changes at a degree of global public health significance:
Increase in transmissibility or detrimental change in COVID-19 epidemiology; or Increase in virulence or change in clinical disease presentation; or Decrease in effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics.
The Omicron B.1.1.529 variant may have a potent infectivity of 500 percent. It is currently the most dangerous novel Coronavirus variant in the world Worldwide, omicron has been reported in South Africa, Israel, Botswana, Belgium and Hong Kong.
In view of the validity of the detection of novel Coronavirus variants, Panodyne® has completed the detection of the latest mutations (including but not limited to Alpha (B.1.1.7), Beta (B.1.351), Gamma (p.1) and Delta) with antigen detection reagents (B.1.617.2), Lambda (C.37), Kappa (B.1.617.1), Eta (B.1525), Lota (B.1526), Mu (B.1.621), Zeta (P.2), Omicron (B.1.1.529), etc.), The testing and theoretical reasoning results confirm detection of Omicron was not missed, ensuring the accuracy and sensitivity of novel Coronavirus antigen detection reagents.